Ventus is applying structural immunology to discover and develop therapeutics targeting innate immune pathways to address human disease.
Total raised: $300M
Founded date: 2019
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 10.02.2022 | Series C | $140M | RA Capital... | marketscre... |
| 08.04.2021 | Series B | $100M | - | finsmes.co... |
| 06.05.2020 | Series A | $60M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 09.02.2022 | Ventus The... | Ventus Therapeutics, Inc., a b... | - | - | marketscre... |
| 09.02.2022 | Ventus The... | Ventus Therapeutics, Inc., a W... | Canada US... | - | finsmes.co... |
| 08.04.2021 | Ventus The... | Ventus Therapeutics, Inc., a b... | - | - | marketscre... |
| 08.04.2021 | Ventus The... | Ventus Therapeutics, Inc., a B... | USA | - | finsmes.co... |
| 06.05.2020 | Ventus The... | WALTHAM, Mass. & MONTREAL-... | - | - | citybizlis... |
| 06.05.2020 | Ventus The... | Ventus Therapeutics, a Waltham... | Canada US... | - | finsmes.co... |
| - | Ventus The... | “Ventus is applying structural... | - | - | fastfounde... |